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Adult intestinal epithelium homeostasis occurs 
through a series of processes, including the in-
testinal stem cells’ self-renewal, proliferation, 
and differentiation and migration of these cells 
toward the intestinal epithelium (Crosnier et al., 
2006). Both the maintenance of tissue homeo-
stasis  and  the  subsequent  development  of   
cancer require the degradation of many pro-
teins  via  the  ubiquitin–proteasome  pathway 
(Hershko and Ciechanover, 1998; Crosnier   
et al., 2006).
The Fbxw7 (F-box/WD repeat–containing 
protein 7; Welcker and Clurman, 2008) gene 
locus  encodes  three  isoforms  (,  ,  and  ), 
each of which is translated from a common 
precursor  messenger  RNA  (mRNA)  with  a 
unique  5  exon  and  10/9  shared  exons  in   
human/mouse,  respectively  (Koepp  et  al., 
2001; Strohmaier et al., 2001; Matsumoto et al., 
2006).  Although  Fbxw7-  is  detected  in  all 
murine tissues, Fbxw7- is restricted to brain 
and testis and Fbxw7- to heart and skeletal 
muscles (Matsumoto et al., 2006). Fbxw7 acts 
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The Fbxw7 (F-box/WD repeat–containing protein 7; also called CDC4, Sel10, Ago, and 
Fbw7) component of the SCF (Skp1/Cullin/F-box protein) E3 ubiquitin ligase complex acts 
as a tumor suppressor in several tissues and targets multiple transcriptional activators and 
protooncogenes for ubiquitin-mediated degradation. To understand Fbxw7 function in the 
murine intestine, in this study, we specifically deleted Fbxw7 in the murine gut using Villin-Cre 
(Fbxw7G). In wild-type mice, loss of Fbxw7 in the gut altered homeostasis of the intestinal 
epithelium, resulted in elevated Notch and c-Jun expression, and induced development of 
adenomas at 9–10 mo of age. In the context of APC (adenomatous polyposis coli) defi-
ciency (ApcMin/+ mice), loss of Fbxw7 accelerated intestinal tumorigenesis and death  
and promoted accumulation of -catenin in adenomas at late but not early time points.  
At early time points, Fbxw7 mutant tumors showed accumulation of the DEK protooncogene. 
DEK expression promoted cell division and altered splicing of tropomyosin (TPM) RNA, 
which may also influence cell proliferation. DEK accumulation and altered TPM RNA  
splicing were also detected in FBXW7 mutant human colorectal tumor tissues. Given  
their reduced lifespan and increased incidence of intestinal tumors, ApcMin/+Fbxw7G mice 
may be used for testing carcinogenicity and drug screening.
© 2011 Babaei-Jadidi et al.  This article is distributed under the terms of an   
Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six 
months after the publication date (see http://www.rupress.org/terms). After six 
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showed  that  Fbxw7  mRNA  was  strongly  expressed  in 
CBCs  and  transiently  amplifying  (TA)  cells  located  in 
crypts (Fig. 1 I, arrowheads), whereas weaker expression of 
Fbxw7 was detected in differentiated villus cells. Fbxw7 ex-
pression was abolished in the Fbxw7G but not in heterozy-
gous Fbxw7G/fl mice (Fig. 1, I and J vs. K). Quantitative 
RT-PCR (qRT-PCR) data also confirmed increased lev-
els of Fbxw7 mRNA expression in the crypt versus villus 
fraction (Fig. 1, L).
All of the aforementioned analyses demonstrate efficient 
deletion of Fbxw7 in Fbxw7G intestinal epithelia but not for 
Fbxw7G/fl heterozygous mice when compared with Fbxw7fl/fl 
mice (Fig. 1, D vs. F and H, I vs. J and K, and L, right). At   
9–10 mo of age, the Fbxw7G mice showed adenomas and 
induction of Peyer’s patch formation (mean three to five) in 
the  large  bowel  (Fig.  S2).  In  addition,  smaller  polyp-like 
structures and initiation of crypt budding and fission were 
found in the small intestine (Fig. S2). These observations in-
dicate that high expression of Fbxw7 in CBCs and TA cells 
located in the crypts may potentially function in intestinal cell 
linage commitments, and the loss of Fbxw7 in both alleles 
could be associated with tumorigenesis.
Adenomatous polyps are induced in the intestines of double 
mutant mice (ApcMin/+Fbxw7G) at an early age
To study the functional importance of Fbxw7 in intestinal 
tumorigenesis and any potential synergy between Fbxw7 and 
APC (adenomatous polyposis coli; Fodde, 2002) in orches-
trating  human  oncosuppression,  we  generated  a  double   
mutant mouse line, ApcMin/+Fbxw7G. The ApcMin/+ mouse is 
a model of human familial adenomatous polyposis, bearing a 
nonsense mutation at codon 850 of the APC gene (Fodde, 
2002) which, combined with a loss of heterozygosity or   
promoter hypermethylation, results in ligand-independent   
activation of the WNT/-catenin pathway (Kennell and   
Cadigan, 2009).
ApcMin/+Fbxw7G mice exhibited rapid tumor development 
throughout the intestine with clearly discernible -cateninHigh 
macroscopic  adenomas  versus  control ApcMin/+Fbxw7fl/fl  mice   
at 3 wk of age (Fig. 2, A and B; and Fig. S3, A–F). All   
ApcMin/+Fbxw7G mice developed adenomas (Fig. 2, A and B; 
and Fig. S3, A–F) without discernible metastases and were 
culled at 3–5 wk of age (Fig. 2 C; n = 14; P < 0.001). In 
contrast,  single  Fbxw7  deletion  compromised  survival  in 
mice, with 42% of the Fbxw7G mice dying after 11–12 mo 
versus the control Fbxw7fl/fl (Fig. 2 C; n = 14). With a 21 ± 
3 wk of maximal mean lifespan (Fig. 2 C; n = 14), both con-
trol ApcMin/+Fbxw7fl/fl and ApcMin/+Fbxw7+/+ yield a very few 
small-sized polyps without macroscopic adenomas at 3 wk of 
age (Fig. S4, A–D). The low frequency of -cateninHigh ade-
nomas from ApcMin/+Fbxw7fl/fl and ApcMin/+Fbxw7+/+ (Fig. S4, 
A–D) was quantified versus ApcMin/+Fbxw7G mice (Fig. 2 D; 
P ≤ 0.001). Epithelial -catenin expression remained un-
changed at 1 and 3 d postpartum in the ApcMin/+Fbxw7G 
versus the control ApcMin/+Fbxw7fl/fl mice (Fig. S4, G and H 
vs. E and F).
as  a  tumor  suppressor,  and  mutations  in  the  Fbxw7  gene   
are  found  in  ovarian  (Kwak  et  al.,  2005),  breast  (Cassia   
et al., 2003; Ekholm-Reed et al., 2004), endometrial (Spruck 
et al., 2002; Cassia et al., 2003), lymphoma (Rajagopalan et al., 
2004),  and  colorectal  (Moberg  et  al.,  2001;  Kemp  et  al., 
2005) cancers.
The Fbxw7 protein belongs to the F-box protein family 
and functions as a receptor subunit for SCF (Skp1/Cullin/ 
F-box protein) E3 ubiquitin ligases (SCFFbxw7; Welcker and 
Clurman, 2008). SCFFbxw7 binds and regulates the abundance 
of proteins in a phosphorylation-dependent manner, as in   
cyclin E (Koepp et al., 2001), c-Myc (Welcker et al., 2004b), 
Aurora-A (Mao et al., 2004a), SRC-3 (Wu et al., 2007), 
SPERB  (Sundqvist  et  al.,  2005),  PGC-1  (Olson  et  al., 
2008), mTOR (Mao et al., 2008), c-Jun (Nateri et al., 2004), 
NICD (O’Neil et al., 2007), and Notch (Wu et al., 2001).
As depletion of Fbxw7 in mice leads to embryonic lethal-
ity (Tetzlaff et al., 2004; Tsunematsu et al., 2004), it remains 
largely unclear how Fbxw7 regulates signaling pathways that 
drive intestinal tissue homeostasis and colorectal cancer (CRC). 
To investigate the role of Fbxw7 in the intestine, we gen-
erated mice with conditional Fbxw7-floxed alleles (Fbxw7fl/fl), 
permitting tissue-specific gene inactivation. We condition-
ally ablated Fbxw7 in the murine intestinal epithelium (Villin- 
Cre+Fbxw7fl/fl or Fbxw7G, as Fbxw7 gut-specific deletion;   
el Marjou et al., 2004) and in the intestinal cancer mouse 
model ApcMin/+ (ApcMin/+Fbxw7G; Fodde, 2002).
In this study, we report that intestinal Fbxw7 inactivation 
induces adenomas. Fbxw7 intestinal cells altered Notch and 
Jun pathways to affect both the fate and the maintenance of 
progenitor cells and proliferating crypt cells. We identify the 
protooncogene DEK as a novel target of GSK-3/SCFFbxw7 
ligase activity that changes alternative RNA splicing of tropo-
myosin (TPM) isoforms. Fbxw7 inactivation impairs degra-
dation of the DEK protooncogene and leads to specific loss 
of the epithelial isoform of TPM, which, cooperatively with 
Notch and Jun, contributes to carcinogenesis in mice.
RESULTS
Deletion of Fbxw7 in the mouse intestine (Fbxw7G) leads 
to intestinal and colonic polyposis
As Fbxw7-null embryos die in utero (Tetzlaff et al., 2004; 
Tsunematsu et al., 2004), we generated a conditional trans-
genic mouse with an Fbxw7 allele, in which exon 5 (encod-
ing  the  F-box  domain)  is  floxed  (Fig.  1  A  and  Fig.  S1). 
Bitransgenic Villin-Cre+Fbxwfl/fl (Fbxw7G) mice were then 
generated to investigate the role of SCFFbxw7 E3 ligase activity 
in the intestine (Fig. S1). Villin-Cre–mediated (el Marjou et al., 
2004) Fbxw7 deletion efficiently and specifically occurred   
in the intestine of Fbxw7G mice compared with Fbxwfl/fl 
(Fig. 1 B). Immunohistochemistry (IHC) analysis of Fbxw7fl/fl 
mice showed that nuclear Fbxw7 was widely expressed in 
the intestinal epithelia, including crypt base cells (CBCs; 
Fig. 1, C and D, red arrowheads), whereas cytosolic Fbxw7 
was hardly detectable (Fig. 1, C and D, black arrowheads). 
In  situ  hybridization  (ISH)  of  Fbxw7  in  Fbxw7fl/fl  mice JEM VOL. 208, February 14, 2011 
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Figure 1.  Targeted gene deletion of Fbxw7 in mouse intestine. (A) Schematic shows the floxed Fbxw7 allele (Fbxw7fl/fl) before and after Cre recom-
bination to generate gut-specific conditional Fbxw7 inactivation (Fbxw7G) mice. Arrows indicate location of PCR primers (black, LoxP; and red, Fbxw7) 
used. (B) PCR analysis of genomic DNA from brain (Br), heart (Hr), and intestine (In) from Fbxw7fl/fl and Fbxw7G mice. OLF-F7/OLR-DF7 PCR shows Fbxw7 
gene status. HPRT was used as a loading control. (C–H) IHC for Fbxw7 on representative intestinal tissue sections of 6-wk-old Fbxw7fl/fl (C and D), 
Fbxw7G/fl (E and F), and Fbxw7G (G and H) mice. Figures are shown at low magnification (C, E, and G) and at high magnification (D, F, and H). Red arrow-
heads show cells with nuclear Fbxw7, and black arrowheads show cells with cytoplasmic Fbxw7. Experiments were performed for each genotype and for 
all four different sections (jejunum, ileum, cecum, and colon) and repeated on at least three independent occasions. (I–K) ISH for Fbxw7 on representative 
intestinal tissue sections of 6-wk-old Fbxw7fl/fl (I), Fbxw7G/fl (J), and Fbxw7G (K) mice. In I and J, yellow arrowheads indicate Fbxw7+ cells in villi, and 
black arrowheads indicate Fbxw7+ cells in crypts. Boxes indicate magnified intestinal crypts. Experiments were performed in duplicate for each genotype 
and repeated on at least two independent occasions. (L) qRT-PCR analysis of Fbxw7 mRNA expression in crypts and villi isolated from Fbxw7fl/fl intestine 
and Fbxw7fl/fl, Fbxw7G/fl, and Fbxw7G whole intestines. Data are mean ± SEM (n = 3; **, P < 0.01; ***, P < 0.001). Experiments were performed in triplicate 
for each genotype and repeated at least on three independent occasions. Bars: (C, E, G, and I–K) 50 µm; (D, F, and H) 10 µm.298 FBXW7 in intestinal homeostasis and cancer | Babaei-Jadidi et al.
small intestine (Fig. S5 D, left vs. right; and not depicted). 
Absorptive enterocytes remained unchanged. To further char-
acterize which epithelial lineages may be involved in tumori-
genesis, intestinal sections were stained with the goblet cell 
marker Mucin 2 (Allen et al., 1998), which showed a re-
markable reduction in Muc2 secretory cells in Fbxw7G mice 
(Fig. S5 E, left vs. right).
We next examined the effects of Fbxw7 depletion on   
intestinal cell division using the proliferation marker Ki67. 
Mutant mice showed a marked increase in proliferating cells 
from all intestinal crypts (Fig. 3 B; data are mean ± SEM;   
n = 3; ≥100 crypts per mouse and for each genotype; and   
Fig. S5 F, left vs. right).
Given these findings, we sought to define the molecular 
links between Fbxw7 loss and consequent changes in intestinal 
epithelium.  The  level  of  intestinal  -catenin  staining  was   
unchanged in either Fbxw7G or the control Fbxw7fl/fl mice at 
5–6 wk (Fig. S5 G, left vs. right). Next, we analyzed several 
oncogenic proteins of known Fbxw7 targets by IHC. Staining 
for Notch 1 (Fig. S5 H, left vs. right) and Notch 4 (Fig. S5 I, 
left vs. right) showed clearly different expression pattern in 
the Fbxw7G CBCs and in Fbxw7fl/fl, respectively. c-Jun was 
detected in the CBCs and at the apex of the villi (Fig. S6,   
A and B) and accumulated within the TA cells in Fbxw7G 
versus Fbxw7fl/fl (Fig. S5 J, left vs. right). These observations 
indicate that depletion of Fbxw7 may cause Notch and c-Jun 
activation  in  progenitor  cells.  This  view  is  supported   
by Western blotting, which also confirmed that the expres-
sion levels of Notch 1, Notch 4, and phosphorylated c-Jun 
Thus, the result suggests that gut-specific Fbxw7 inactiva-
tion in the ApcMin/+ (ApcMin/+Fbxw7G) mice induces tumori-
genesis and compromises lifespan and survival. In addition, 
loss of Fbxw7 in the context of APC deficiency may acceler-
ate extensive intestinal tumorigenesis in mice without an   
immediate Wnt/-catenin activation, at 3 d postpartum but 
with substantial -catenin accumulation in adenomas at 3 wk 
of age. This observation suggests that the accumulation of   
-catenin may require additional activators after longer loss 
of Fbxw7 or APC to cause progressive development of intes-
tinal adenomas (Phelps et al., 2009).
Notch and Jun signaling pathways alter both the fate  
of progenitor cells and the maintenance of proliferating 
crypt cells in Fbxw7 intestinal cells
To investigate the mechanisms by which mutated Fbxw7 
may lead to cancer development, our subsequent analysis was 
focused on young Fbxw7G mice that showed signs of altered 
intestinal epithelial cell (EC) composition accompanied by an 
induction of apoptosis in cells located in crypts positive for 
active caspase-3 at position 4–5 (Fig. S5, A and B, left vs. 
right). There was an increase of apoptotic cells by >55% in 
the small intestine and 30% in the large bowel in the crypts of 
Fbxw7G mice when compared with floxed mice (Fig. 3 A; 
data are mean percentage ± SEM; n = 3; ≥200 crypts/mouse 
and for each genotype).
However, Fbxw7G intestines exhibited a significant loss 
of goblet cells (Fig. S5 C, left vs. right), along with signifi-
cantly fewer Paneth and enteroendocrine cells in the Fbxw7G 
Figure 2.  In the ApcMin/+ mouse, gut-
specific conditional Fbxw7 inactivation 
(ApcMin/+Fbxw7G mice) induced tumori-
genesis and compromised lifespan and 
survival. (A and B) H&E staining (A)  
and IHC for -catenin (B) on duodenum 
from 3-wk-old ApcMin/+Fbxw7G mice.  
Experiments were performed in duplicate  
for all four different sections for each geno-
type and repeated on at least two indepen-
dent occasions. Dashed lines indicate 
intestinal polyps and adenomas (A, green) 
expressing high amounts of -catenin  
(B, black). Bars, 100 µm. (C) Kaplan-Meier 
survival curves for Fbxw7G, ApcMin/+Fbxw7fl/fl, 
and ApcMin/+Fbxw7G mice showing the  
percentage of mice remaining alive at 1-wk 
intervals. The x axis indicates times (weeks) 
until mice were euthanized because of  
severe weight loss. Groups of 14 mice per 
genotype were used for analysis, and survival 
curves were statistically different from  
each other (P < 0.001). (D) -Catenin polyps 
(graph shows mean ± SEM) were counted  
in ApcMin/+Fbxw7fl/fl and ApcMin/+Fbxw7G  
mice (n = 4 of each genotype according  
to intestinal locations) on two  
independent occasions.JEM VOL. 208, February 14, 2011 
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Math-1 (Yang et al., 2001), providing further evidence of   
the effect of Notch overactivation on the differentiation of 
Fbxw7G  intestinal  secretory  precursor  cells.  Mice  lacking 
Hes-1, Math-1, and ngn-3 show a reduction of goblet, Paneth, 
and enteroendocrine cells, which may indicate a common 
progenitor cell for these secretory cell lineages (Jensen et al., 
2000; Yang et al., 2001; Jenny et al., 2002).
In the large bowel, CD44 protein expression is normally 
restricted to the crypt compartment, and expression of cd44 
from Fbxw7G mice was significantly increased (Fig. 3 E and 
Fig. S5 K, left vs. right). CD44 is a c-Jun target, and it is in-
duced in intestinal tumors (Nateri et al., 2005; Van der Flier 
et al., 2007). However, induction of CD44 may change the 
proliferative  status  of  the  intestinal  progenitor  cells  when 
Fbxw7 is inactivated (Fig. S5 F, left vs. right).
Proteomic analysis identified induction in the level  
of the DEK protooncogene and high molecular weight TPM 
isoform in Fbxw7 intestine
Because -catenin may not been involved in the early events 
of intestinal cancer initiation in our mutant mice (Fig. S4,   
E–H; and Fig. S5 G, left vs. right), we examined whether 
(p–c-Jun) are increased in Fbxw7G versus Fbxw7fl/fl intestine, 
whereas cyclin E and p–c-Myc are less affected (Fig. 3 C).
Consistent with our observed changes in secretory cell 
differentiation, the Paneth cell marker crypt-1 (cryptidin-1), 
the enteroendocrine cell marker chgA (chromogranin A), and 
the  goblet  cell  marker  muc2  (mucin  2)  were  reduced  in 
Fbxw7G intestines (Fig. 3 D). To evaluate the role of Notch 
and c-Jun signal activation on the differentiation and prolif-
eration of intestinal ECs (Fig. S5, A–E), we measured the 
relative mRNA expression of several Notch/Jun downstream 
targets by qRT-PCR (Table S1). In general, intestinal ex-
pression levels of Hes-1 (hairy and enhancer of split 1), c-jun, and 
cd44 were increased, whereas the level of Hes-5 was not sig-
nificantly affected (Fig. 3 E). Expression of secretory pro-
genitor markers Math-1 (mouse atonal homologue 1) and ngn-3 
(neurogenin-3) were also significantly repressed (Fig. 3 D).
Hes-1 expression is transcriptionally activated by Notch 
and is considered the canonical Notch downstream target 
gene (Jarriault et al., 1995). Hes-1 deletion led to excessive 
numbers of goblet, enteroendocrine, and Paneth cells. Hes-1/ 
mice showed no changes in intestinal proliferation; the up-
regulation of Hes-1 resulted in the repression of ngn-3 and 
Figure 3.  Protein expression of Fbxw7 substrates and mRNA levels of genes responsible for intestinal differentiation, proliferation, and 
progenitor markers are altered in Fbxw7G intestinal ECs. (A) The mean percentage of caspase-3+ cells (±SEM) in crypts of Fbxw7fl/fl and Fbxw7G 
mice (n = 3 for each genotype; 200 crypts each; ***, P < 0.001). (B) Ki67-stained cells in crypts of Fbxw7fl/fl and Fbxw7G mice (n = 3 for each genotype; 
100 crypts each) according to intestinal locations. Data present mean per crypt ± SEM (n = 3; ***, P < 0.001). (C) Western blot analysis of Fbxw7fl/fl and 
Fbxw7G intestinal proteins using antibodies against Fbxw7, Notch 1, Notch 4, p–c-Jun, p–c-Myc, cyclin E, and the loading control -actin. Experiments 
were performed on at least two independent occasions. IB, immunoblot. (D and E) qRT-PCR analysis of mRNA encoding the indicated genes responsible 
for intestinal differentiation, proliferation, and marking progenitors in Fbxw7G and Fbxw7fl/fl intestine. Results were normalized to -actin in the same 
sample, and data are presented as fold induction/repression over Fbxw7fl/fl mice. Mean ± SD (n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001). Experiments 
were performed in triplicate for each genotype and repeated on at least three independent occasions.300 FBXW7 in intestinal homeostasis and cancer | Babaei-Jadidi et al.
Subsequent amino acid sequencing and bioinformatic analyses 
identified several proteins known to be involved in carcinogen-
esis. Among others, we identified different isoforms of TPM  
and  mouse proteins with high (Fig. 4 D, yellow circles)   
and low (Fig. 4, B and D, blue circles) molecular weights 
(Fig. 4, B vs. D and F vs. H) and also a nuclear phosphoprotein 
other cell regulators can be involved at these earlier stages. 
Proteins either absent in control Fbxw7fl/fl or differentially ex-
pressed in Fbxw7G intestines were identified from cytosolic 
(Fig. 4, A vs. C) and nuclear (Fig. 4, E vs. G) protein extracts using 
two-dimensional matrix-assisted laser desorption/ionization 
(MALDI)–mass spectrometry (MS) assays (Kim et al., 2007). 
Figure 4.  Expression of DEK and TPM is altered in the intestine of Fbxw7G mice. (A–H) Two-dimensional gel/MS-based protein identification 
using mouse intestinal proteins fractionated into cytosolic (A, Fbxw7fl/fl; C, Fbxw7G) and nuclear extracts (E, Fbxw7fl/fl; G, Fbxw7G). Circled areas in A, C, E, 
and G are magnified and shown in B, D, F, and H. Blue and yellow circles (B and D) denote isoforms of Tpm; the red circle (H) denotes DEK. (I–L) IHC for 
TPM and DEK on representative intestinal tissues of 6-wk-old Fbxw7fl/fl (I and K) and Fbxw7G mice (J and L). Dashed lines indicate the boundary of the 
muscle and epithelia. Arrowheads denote DEK-expressing cells. Bars, 50 µm. (M) Western blot analysis of TPMs in epithelia-enriched and whole intestine 
protein samples from Fbxw7fl/fl and Fbxw7G mice. Arrows indicate possible transition of TPM isoforms. (N) Western blot analysis of Fbxw7fl/fl and Fbxw7G 
intestines with DEK, Muc2, and -actin (loading control) antibodies. (O) qRT-PCR analysis of DEK mRNA in the intestine of Fbxw7G and Fbxw7fl/fl mice. 
Results were normalized to -actin expression in the same sample, and data are presented as fold over Fbxw7fl/fl mice (mean ± SD; n = 3; ***, P < 0.001). 
Experiments were performed in triplicate for each genotype and repeated on at least three independent occasions.JEM VOL. 208, February 14, 2011 
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ECs are correlated with FBXW7 mutations in human colon 
cancer (Fig. 5, E–N; and Tables S2 and S3). TPM expression 
was elevated in smooth muscle (stromal) cells from FBX-
W7mut tumors when compared with FBXW7wt tumors (Fig. 5, 
H vs. L). Quantification data, consistent with our mouse model 
observation, show that TPM expression in epithelia decreased 
with FBXW7 mutation (Table S3; P = 0.0024), whereas its 
expression was elevated in stroma compared with FBXW7wt 
tumors (Table S3; P = 0.0106; and Table S2). DEK staining 
was more intense in FBXW7mut ECs (Fig. 5, J vs. N), revealing 
its high levels of expression in FBXW7mut tumor tissues 
(Table S3; P = 0.0010).
Notably, lower expression of TPM expression is corre-
lated with a high level of DEK expression in ECs (Fig. 5,   
H vs. J and L vs. N). Collectively, these data show that accu-
mulation of DEK and loss of epithelial TPM may contribute 
to the oncogenicity of FBXW7 mutation in both human 
CRC and in the ApcMin/+Fbxw7G mouse intestine, which is 
indicative of possible roles for DEK and TPM in colorectal 
tumorigenesis (Prasad et al., 1993; Bharadwaj and Prasad, 
2002; Mlakar et al., 2009; Wise-Draper et al., 2009).
To test whether there was a functional relationship be-
tween CRC cell proliferation and their FBXW7 status, single 
HCT116 cells lacking or expressing FBXW7 (Mao et al., 
2004a; Mao et al., 2008), HCT116/, HCT116+/, and 
HCT116+/+ cells, were cultured for colony forming assays 
(Fig. S8 A). Both CRC HCT116+/ and HCT116/ cell 
lines, harboring deletion of FBXW7 caused an increase in 
size and number of cell colonies (Fig. 5 O; 0.0001 < P < 0.05). 
In separate tissue culture studies, we investigated the role that 
TPM  may  play  in  CRC  cells.  Expression  of  TPM1-  is 
widely distributed in both smooth muscle cells and the cyto-
skeleton of ECs (Gunning et al., 2005; Helfman et al., 2008). 
Therefore, the effects of TPM expression on proliferation, 
cell migration, and wound healing were then tested in both 
HCT116+/+ and HCT116/ cells. Both cells were thus trans-
fected with FLAG–TPM1- and compared with pcDNA back-
bone vector (control)–transfected cells (Fig. S8 B). We observed 
that ectopic expression of TPM1- increased cell number in 
G0/G1 phase and decreased the number of cells in S phase in 
both HCT116/ and HCT116+/+ cells (Fig. 5 P; 0.0001 <   
P < 0.001). A wound healing assay using the aforementioned 
transfection protocol in both cells lines (HCT116/ and 
HCT116+/+) was performed, in which overexpression of 
TPM1-  repressed  wound  healing  (Fig.  5  Q;  0.0001  <   
P < 0.05; and Fig. S8 C). Transfection of FLAG–TPM1- 
significantly reduced HCT116+/+ (P < 0.001) and HCT116/ 
cell motility in trans-well migration assay (P = 0.043). West-
ern  blotting  analyses  suggest  that  ectopic  expression  of 
TPM1- in both HCT116/ and HCT116+/+ cells led to 
an increased level of E-cadherin (Fig. S8 B), which is sugges-
tive of wound healing and cell migration repression (Fig. 5, 
Q and R). We also found that c-Jun protein levels were de-
creased in cells transfected with TPM1- (Fig. S8 B), which 
is a plausible functional correlation to reduced cell prolifera-
tion (Fig. 5 P).
DEK (Fig. 4 H, red circle), all of which were subsequently   
verified by Western blotting and IHC on Fbxw7fl/fl and 
Fbxw7G intestines.
TPM is comprised of tissue-specific isoforms, including 
skeletal muscle, smooth muscle, fibroblast, and epithelial iso-
forms that range 32–45 kD (Gunning et al., 2005; Helfman 
et al., 2008). TPM staining of Fbxw7fl/fl intestine showed a 
cytoplasmic pattern in the smooth muscle cells and vesicular 
staining in apical ECs (Fig. 4 I) in 6-wk-old mice. In contrast, 
less apical epithelial staining but stronger staining of the 
smooth  muscle  cells  was  found  in  the  Fbxw7G  intestine   
(Fig. 4 J). Consistent with this, Western blots of TPM on   
villus-enriched fractions showed a remarkable reduction in the 
level of epithelial isoforms (Fig. 4 M, left), whereas TPM on 
whole intestine (epithelia and muscles) showed an increase in 
the higher molecular weight isoform (Fig. 4 M, right). The 
finding shows a remarkable transition of TPM protein isoforms 
in the Fbxw7G compared with control Fbxw7fl/fl intestine.
We next examined which Fbxw7 isoform regulates the 
E3 ligase activity toward TPM degradation and found that 
the level of overexpressed TPM1- protein (Houle et al., 
2007) was not affected by overexpression of the FBXW7 iso-
forms in human CRC HCT116 cells (Fig. S7 A). These data 
suggest that Fbxw7 may not directly influence the TPM pro-
tein level but may indirectly affect TPM alternative splicing 
(Gooding and Smith, 2008).
DEK (Fig. 4 H), a nuclear phospho-protooncogene pro-
tein, is implicated in carcinogenesis and up-regulated in a va-
riety of aggressive human tumors (Waldmann et al., 2004; 
Carro et al., 2006). IHC analysis demonstrated intense stain-
ing of DEK in crypt cells from Fbxw7G intestine (Figs. 4,   
K vs. L, arrowheads), and Western blotting also confirmed an 
increased  level  of  DEK  in  Fbxw7G  intestine  (Fig.  4  N).   
We measured relative DEK expression with real-time qRT-
PCR (Table S1) and found that DEK mRNA expression was 
normal (Fig. 4 O). These data suggest that loss of SCFFbxw7  
E3 ligase activity can result in the accumulation of DEK   
protein level.
DEK and TPM expression is associated with the early 
transformed phenotype in ApcMin/+Fbxw7G mice
-Catenin  levels  in  the  epithelia  of  ApcMin/+Fbxw7G  and 
control ApcMin/+Fbxw7fl/fl mice at early age (3 d postpartum) 
do not show an apparent difference (Fig. S4, F vs. H); indeed, 
IHC analysis detected transformation of TPM isoform com-
position from the epithelial isoform in ApcMin/+Fbxw7fl/fl mice 
to the muscle isoform in ApcMin/+Fbxw7G mice 3 d postpar-
tum (Fig. 5, A vs. B, arrowheads). Results also showed a high 
level of DEK in the intestines of ApcMin/+Fbxw7G mice 3 d 
postpartum (Fig. 5, C vs. D). Highly elevated DEK levels 
were also observed in adenomas of adult double mutant mice 
(unpublished data). Therefore, we investigated whether DEK 
and TPM play a role in the regulation of cell growth.
Comparable IHC analysis on wild-type FBXW7 (FBX-
W7wt) and FBXW7 mutated (FBXW7mut) human colorectal 
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Figure 5.  TPM abolishment in epithelium and DEK accumulation in crypt of ApcMin/+Fbxw7G mice and human colorectal tumors. (A–D) The 
expression pattern of DEK and TPM of day 3 postnatal ApcMin/+Fbxw7fl/fl (A and C) and ApcMin/+Fbxw7G (B and D) intestinal tissues. Dashed lines indicate 
the boundary of the muscle and epithelia. (E–N) IHC for TPM and DEK on representative human colorectal tissues. (E and F) IHC for TPM and DEK in repre-
sentative sections of normal human colorectal tissues. (G–N) IHC for TPM and DEK in sections of human colorectal tumors with and without FBXW7  JEM VOL. 208, February 14, 2011 
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DEK contains phosphorylation motifs similar to the CDC4-
phospho-degron described in other Fbxw7 target proteins 
(Welcker and Clurman, 2008). In particular, DEK protein 
harbors four GSK-3 phosphorylation clusters (Fig. S7 B), 
two at the N terminus (Thr15 and Thr67) and the other two at 
the C terminus (S169 and S227; Kappes et al., 2004). How 
DEK protooncogene function and its expression levels are 
regulated is largely unclear.
In examining which FBXW7 isoform regulates the E3   
ligase activity toward DEK degradation, it is apparent that 
overexpression of the FBXW7 isoforms in a human cell line 
HEK293T reveals that DEK, in the presence of GSK-3, is 
targeted  by  FBXW7-  and  less  so  by  FBXW7-  and 
FBXW7- (Fig. 6, A [lane 1 vs. lanes 2 and 3] and C [lane 2 
vs. lane 1]). Overexpression of Fbxw7- in HEK293T did 
not alter DEK mRNA levels (unpublished data). Moreover, 
GFP-DEK100 (100-aa deletion mutation at N terminus of 
DEK protein) co-overexpressed with FBXW7- was un-
changed (Fig. S7 C). Indeed, phosphorylation occurs at the 
N terminus of DEK protein upon in vitro translation (IVT) 
of DEK(1–100) in rabbit reticulocyte (RT) lysates, which 
was observed with higher electrophoretic mobility and treat-
ment of RT lysates containing p-DEK with -phosphatase, 
resulting  in  an  unphosphorylated,  faster-migrating  form   
(Fig. 6 B, top). Consistent with this, previous data also con-
firmed N-terminal DEK phosphorylation by in vitro kinase 
assays in which DEK was translated in vitro in RT lysates 
(Soares et al., 2006).
Mutations at either Thr15 or Thr67 also did not stabilize 
DEK (unpublished data). In contrast, both phosphorylation 
clusters of DEK mutant protein (DEKT15,67A or DEK2A;   
Fig. 6 B, bottom) are similar in the presence or absence of 
FBXW7- (Fig. 6 C, lanes 4 and 5), suggesting that both   
N-terminal phosphorylation clusters at Thr15 and Thr67 con-
tribute to recognition of DEK by SCFFBXW7- for degrada-
tion. Blocking phosphorylation and inhibition of GSK-3 
expression using LiCl or proteasome inhibitor–stabilized   
p-DEK (Fig. 6 C, lanes 3 and 6 vs. lane 2). p-DEK was stable 
in HEK293T cells (Soares et al., 2006), but coexpression of 
FBXW7 decreased the steady-state levels of DEK and re-
sulted in reduced protein half-life (Fig. 6 D; Nateri et al., 2004). 
In contrast, the stability of DEK2A mutant protein was not   
affected in the presence of Fbxw7 (Fig. 6 D). These data sug-
gest that the E3 ligase SCFFbxw7- degrades p-DEK in a GSK-
3–dependent manner. Consistent with this, HCT116/ 
We then tested whether DEK induces CRC cell division. 
HCT116 cells were transfected with the GFP-DEK expres-
sion vector (HCT116GFP-DEK) and DEK-specific duplex small 
interfering  RNA  (siRNA;  HCT116DEK),  and  cell  cycles 
were compared with cells transfected with sequence scram-
bled  control  siRNA  (control;  HCT116ssc).  Two  different 
siRNA duplexes were used, and down-regulation of DEK 
was similar (Fig. S8 D). DEK knockdown significantly in-
creased cell number in G0/G1 phase (P < 0.001) and de-
creased the number of cells in S phase (Fig. 5 S, gray bars). In 
contrast, ectopic expression of GFP-DEK increased the num-
ber of cells forming the S-phase plateau (HCT116GFP-DEK vs. 
HCT116ssc;  P  <  0.001)  as  well  as  the  G2/M-phase  peak 
(HCT116GFP-DEK vs. HCT116ssc; P < 0.05; Fig. 5 S, gray 
bars), thus suggesting that DEK might play a role in inducing 
cell division.
To elucidate whether nuclear accumulation of oncogenic 
-catenin in the ApcMin/+ mice and oncogenic DEK in the 
Fbxw7G mice cooperate in carcinogenesis as in the ApcMin/+ 
Fbxw7G  mice,  we  examined  -catenin  levels  in  human 
CRC HCT116/ cells, which harbor deletion of FBXW7 
and a -catenin phosphorylation site mutation. Both -catenin 
and DEK protein levels were increased in HCT116/ cells 
(Fig. 5 T), suggesting that HCT116/ cells may mimic the 
molecular defects of adenomas developed by ApcMin/+Fbxw7G 
mice. Fbxw7 and -catenin coimmunoprecipitation (co-IP) 
experiments  did  not  show  a  direct  interaction  between 
Fbxw7 and -catenin proteins overexpressed in HEK293T 
cells (unpublished data). Thus, SCFFbxw7 E3 ligase activity 
may not directly influence the level of -catenin. Therefore, 
collectively, these observations from the double mutant mice 
and human CRC tissues and cells support the conclusion that 
DEK accumulation and TPM suppression could be necessary 
events for the transformed phenotype.
GSK-3/ SCFFbxw7- E3 ligase activity regulates  
DEK degradation
DEK is involved in gene transcription and RNA splice site 
recognition (Soares et al., 2006). Posttranslational modifica-
tions play an important role in regulating DEK’s binding to 
DNA and chromatin proteins (Alexiadis et al., 2000; Kappes 
et al., 2004), and the interaction of DEK with U2AF-RNA 
requires phosphorylation (Soares et al., 2006). DEK is highly 
phosphorylated by multiple kinases (Kappes et al., 2004; 
Soares et al., 2006), and sequence comparison reveals that 
mutations. H, J, L, and N show magnified versions of the boxed regions in G, I, K, and M. (A and H) Arrowheads indicate TPM+ cells. SM, smooth muscle 
cell. (O) HCT116 human CRC cells expressing the indicated FBXW7 genotypes were cultured in vitro. Graph shows mean ± SEM, and numbers in parentheses 
indicate the number of colonies generated from 50 cells seeded in 24-well dishes in triplicate and on two independent experiments. (P–R) FLAG–TPM1- 
or control vector (pcDNA) was expressed in HCT116+/+ and HCT116/ cells, and status was monitored for cell cycle via flow cytometry and propidium 
iodide staining (P). Wound healing (Q) and cell migration (R) were also performed. For quantification of colony area and wound healing, images of 
wounds and colonies were converted into binary images using the ImageJ program. (S) Cell cycle status of HCT116 cells transfected with expression vec-
tor pGFP-DEK (HCT116GFP-DEK), DEK-specific duplex siRNA (HCT116DEK), and sequence scrambled control siRNA (HCT116ssc) was monitored via flow cytom-
etry and propidium iodide staining in triplicates. (O–S) Error bars present mean ± SEM of three independent experiments (*, P < 0.05; **, P < 0.01;  
***P < 0.001). (T) DEK, FBXW7, GSK-3, and -catenin expression was measured by Western blotting. Bars: (A–G, I, K, and M) 50 µm; (H, J, L, and N) 10 µm.
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Figure 6.  DEK is regulated by the SCF E3 ligase containing the FBXW7- subunit in a manner dependent on GSK-3. (A) FLAG-tagged  
versions of the indicated proteins were expressed in HEK293T cells, and lysates were subjected to immunoblotting with anti-FLAG and anti-GFP. -Actin 
was used as a loading control. (B) 35S-labeled DEK was generated by IVT using rabbit RT lysates, with or without -phosphatase (PPase) treatment. Sche-
matic shows potential GSK-3 phosphorylation sites on DEK; red letters document residues mutated in DEK2A. SE, short exposure; LE, long exposure.  
(C and D) Mutant and wild-type versions of DEK together with other indicated constructs were expressed in HEK293 cells. Cells were treated or not with 
LiCl and/or proteasome inhibitor I (Prot Inhib) for 8 h (C) or cycloheximide (CHX; D) for the indicated time points. Lysates were examined by Western blot-
ting. (E) HCT116 cells lacking or expressing FBXW7 were transfected with the indicated constructs, labeled with [35S]methionine, and chased with cold 
methionine for the indicated time points. Lysates were subjected to IP and immunoblotting with anti-GFP. (F) HEK293T cells were transfected with the 
indicated constructs and subjected to IP and immunoblotting with the indicated antibodies. The asterisk indicates a nonspecific band. (G) FLAG-FBXW7 JEM VOL. 208, February 14, 2011 
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Intestinal tumorigenesis promoted by the accumulation  
of proliferating cells in the crypts of ApcMin/+Fbxw7G mice
Intestinal tumor formation in ApcMin/+Fbxw7G mice appar-
ently occurs by repopulation of preexisting crypts (unpub-
lished data) with APC mutant cells, as reported for humans 
(Shih et al., 2001). To determine whether Fbxw7 depletion 
results in the rapid transformation of intestinal crypt cells into 
adenomas in ApcMin/+Fbxw7G, we examined the prolifera-
tion index of mutants versus litter mate control mice at dif-
ferent  ages.  Results  showed  that  ApcMin/+Fbxw7G  mice 
significantly  induced  proliferation  compared  with  control 
ApcMin/+Fbxw7fl/fl mice at 3 d postpartum (measurement as 
Ki67+ cells/micrometer; P < 0.001; Fig. 8 A). Ki67+ cells 
were also significantly increased in Fbxw7G crypts compared 
with Fbxw7fl/fl at 3 wk old (measurement as Ki67+ cells/crypt; 
P < 0.001; Fig. 8 B). Further molecular characterization on 
protein extracts from small intestine isolated at 3 d postpartum 
indicated that in the ApcMin/+Fbxw7G, the levels of Notch 1,   
c-Jun, and DEK were significantly increased (Fig. 8 C), simi-
lar to the levels present in the Fbxw7G intestine (Figs. 3 C 
and 4 N). CyclinD1 protein levels, a positive proliferation 
marker, were also increased, and TPM protein expression 
patterns consequently changed (Fig. 8 C). We concluded that 
Fbxw7G crypt cells bearing multiple subsequent deregula-
tions in Notch, Jun, and DEK activation result both in early 
tumor initiation and proliferation and in an increase of tumor 
incidence at 2–3 wk of age.
DISCUSSION
Despite the well-established links between signaling and 
transcriptional activity, little is known about how transcrip-
tional activators/repressors are regulated once tumorigenesis 
has been triggered. One mechanism is by limiting the life-
time of an activator/repressor by destroying it via the ubiq-
uitin–proteasome system (Nakayama and Nakayama, 2006; 
Welcker and Clurman, 2008). Our study reveals a previ-
ously unrecognized role for SCFFBXW7 E3 ligase and its 
substrates  in  regulating  intestinal  epithelial  homeostasis   
and tumorigenesis.
In this study, the Fbxw7G mice at 9–10 mo of age 
showed adenomas, and crypt budding and fission were also 
found in the small intestine (Fig. S2). Crypt budding and 
fission occur in normal intestinal growth and repair as well 
as in polyposis. It has been suggested that these events   
occur when the number of intestinal stem cells in a crypt 
exceeds a threshold (Brittan and Wright, 2002). However, 
further analysis is required to validate this concept in our 
mutant mice. Furthermore, inactivation of both Fbxw7 and 
APC appears to be synergistically accelerating the malig-
nant progress from adenoma to adenocarcinoma (Fig. 2 
and Fig. S3).
cells restored the stability of ectopic expression of DEK pro-
tein (Fig. 6 E). Therefore, DEK protein level may be directly 
modulated by SCFFbxw7- E3 ligase activity.
IP of FLAG epitope–tagged FBXW7-–GFP revealed its 
interaction with p-DEK–GFP protein (Fig. 6 F, lane 3) in 
HEK293T cells. Also, IP of in vitro translated FLAG-tagged 
Fbxw7 showed a direct interaction with the DEK protein 
(Fig. 6 G). We next examined whether FBXW7 possesses E3 
ligase activity toward p-DEK by assessing DEK ubiquitina-
tion in HEK293T cells (Wu et al., 2007). DEK was efficiently 
ubiquitinated (Fig. 6 H, lane 3 vs. lanes 1 and 2), and there-
fore SCFFBXW7 has properties consistent with a function as an 
E3 ubiquitin ligase that specifically targets p-DEK.
FBXW7-–mediated degradation of DEK influences TPM 
RNA splicing
Recent experiments have demonstrated that p-DEK influ-
ences alternative splicing of RNA (Soares et al., 2006). We 
examined whether deregulated p-DEK changes alternative 
RNA splicing of TPM (Fig. 4, I vs. J and M; Gooding and 
Smith, 2008). We used a double reporter system for deter-
mining  splicing  efficiency  (Fig.  7  A;  Nasim  and  Eperon, 
2006). A short splicing region containing TPM target intron 
and its splicing sites (ss) was introduced between two report-
ers  encoding  -galactosidase  (-gal)  and  luciferase  (Luc), 
such that the upstream -gal is expressed regardless of splic-
ing (Fig. 7 A). However, the Luc will be expressed unless the 
multiple stop-codons (reds) residing in the splicing region   
are removed (Fig. 7 A). Therefore, the proportion of tran-
script variants can be evaluated by the relative ratio of Luc to 
-gal expression.
We show that endogenous p-DEK (Fig. 7 B, lane 1) but 
not unphosphorylated DEK (Fig. 7 B, lane 5), significantly 
enhanced the TPM RNA splicing efficiency. A similar ob-
servation was made when DEK was overexpressed in the 
presence and absence of GSK-3 (Fig. 7 B, lane 3 vs. lane 7). 
Therefore, the phosphorylation of DEK by GSK-3 is a cru-
cial step to mediate Tpm RNA splicing. Intriguingly, p-DEK 
targeted by FBXW7 significantly reduced the splicing effi-
ciency (Fig. 7 B, lanes 2 and 4 vs. lanes 1 and 3). In addition, 
the assessment of splicing efficiency by the Luc/-gal ratio 
was also independently confirmed by RT-PCR (Fig. 7 C). 
Consistent with our mouse model (Fig. 4 M), enhanced DEK 
in HCT116/ cells is sufficient to facilitate TPM shifts to a 
higher molecular weight (Fig. 7 D, arrowhead). DEK deple-
tion in HCT116/ using the DEK-specific duplex siRNA 
significantly reduced TPM RNA splicing efficiency (Fig. 7 
E, left) and also reduced the TPM shifts to the higher molec-
ular weight (Fig. 7 E, right). These data suggest that TPM 
splicing is directly regulated by GSK-3/DEK, which in turn 
is subjected to SCFFBXW7 E3 ligase activity.
was generated by IVT, and interaction with DEK-GFP was probed by IP and immunoblotting with the indicated antibodies. (H) HEK293T cells expressing 
the indicated constructs and HA-tagged ubiquitin (HA-Ub) were subjected to IP and immunoblotting with the indicated antibodies. Experiments in B and 
E–H and A, C, and D were repeated at least two and three times, respectively.
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regulation of cell fate specification predominantly by Hes-1 
(Fre et al., 2005; van Es et al., 2005). The induction of Hes-1 
but not Hes-5 presumably indicates that these genes could be 
regulated by additional transcription factors as well as Notch 
and consequently has overlapping but distinct patterns of 
Fbxw7G mice showed activation of Notch, c-Jun, and 
their downstream targets (Fig. 3 and Fig. S5, G–K). How-
ever, our result is consistent with recent reports that activa-
tion of the Notch signaling pathways mainly induced Hes-1 
but not Hes-5 expression; Notch signaling is implicated in the 
Figure 7.  GSK-3–p-DEK regulates TPM alternative splicing. (A) Schematic of bicistronic reporter construct, TN24tm, used for splicing test. Tpm 
splicing sites are uppercase and introns are lowercase letters. Splicing and nonsplicing patterns of -gal and Luc proteins are shown in boxes. Arrows 
indicate the location of primers for RT-PCR analyses. Red letters indicate stop codons. Ad, adenovirus; pA, poly A signal; SK, skeletal muscle. (B) TN24tm 
splicing activity assessed by Luc and -gal expression in HCT116 cells expressing the indicated constructs. Histogram shows the ratio of Luc/-gal expres-
sion (mean ± SEM from three independent experiments). (C) RT-PCR analyses of TN24tm splicing efficiency using RNA from HCT116 cells cotransfected 
with the indicated constructs. (D) HCT116 cells lacking or expressing FBXW7 were subjected to immunoblotting with the indicated antibodies. The arrow-
head marks a higher molecular weight form of TPM. (E) TN24tm splicing assays in HCT116/ cells transfected with DEK-specific duplex siRNA or scram-
bled control siRNA. Left panel presents the ratio of Luc/-gal expression (mean ± SEM from three independent experiments). Middle panel represents the 
RT-PCR analysis. Right panel shows Western blotting with the indicated antibodies. Arrowheads mark a higher and lower molecular weight form of TPM. 
The asterisk indicaets a nonspecific band.JEM VOL. 208, February 14, 2011 
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intestinal tumorigenesis (Nateri et al., 
2005; Akiyoshi et al., 2008; Fre et al., 
2009; Sancho et al., 2009). However, 
Muc2 inactivation also causes intesti-
nal tumor formation (Velcich et al., 
2002). Alternatively, expression of the 
cell cycle regulator cyclin E and the 
oncogene  c-Myc  were  unaffected   
by loss of intestinal Fbxw7. Cyclin E   
expression  is  not  always  increased   
in  Fbxw7-deficient  cells  and/or  in 
Fbxw7/ embryos (Mao et al., 2004b; 
Rajagopalan et al., 2004; Tsunematsu 
et al., 2004). In addition, cyclin E lev-
els were not affected in Fbxw7-defi-
cient T cells (Onoyama et al., 2007). 
It  is  therefore  possible  that  Fbxw7 
mediates  cyclin  E  degradation  in  a   
tissue-dependent  manner.  Recent 
studies have also identified Fbxw7- 
as the major player mediating c-Myc degradation (Welcker   
et al., 2004a; Bonetti et al., 2008), and it may not be affected 
in our mice because of the low level of endogenous intestinal 
Fbxw7- isoform expression. Accordingly, we showed that 
nuclear Fbxw7- is the major isoform present in intestinal 
epithelia (Fig. S6 D).
The up-regulation of -catenin in adenomas from double 
mutant (ApcMin/+Fbxw7G) mice at 3 wk of age (Fig. 2 and 
Fig. S3) and in HCT116/ cells indicates a cross talk be-
tween  Wnt/-catenin  signaling  and  FBXW7.  However, 
Fbxw7-deleted intestinal epithelia did not lead to a significant 
accumulation of -catenin in the intestines of 5/6-wk-old 
Fbxw7G mice (Fig. S5 G, left vs. right) and in 3-d-postnatal 
ApcMin/+Fbxw7G mice (Fig. S4, F vs. H). We conclude that 
-catenin accumulation may require additional factors after 
prolonged Fbxw7 or APC loss (Phelps et al., 2009).
Although it has already been demonstrated that different 
TPM isoforms are implicated in neoplastic-specific altera-
tions and that decreased expression of specific nonmuscle 
TPM isoforms is commonly associated with the transformed 
phenotype (Helfman et al., 2008), we detected loss of epithe-
lial  isoforms  of  TPM  in  3-d-postpartum  ApcMin/+Fbxw7G 
mice (Fig. 5, A vs. B, arrowheads). Furthermore, a strong 
expression in the gut. Whereas Hes-1, -6, and -7 transcripts 
were apparently restricted to the crypt region, Hes-5–expressing 
cells were also found in the villus epithelium and in the mes-
enchyme (Schröder and Gossler, 2002). Consistent with pre-
vious  studies  (Schröder  and  Gossler,  2002;  Riccio  et  al., 
2008), Notch 1 was most prominently expressed in ECs of 
the crypts (Fig. S5 H, left vs. right), where Fbxw7 is also 
highly expressed (Fig. 1 I), presumably by mediating Notch 1 
down-regulation, and consequently Hes-1 was more affected 
than Hes-5.
We and others have reported that activation of the c-Jun 
and Notch signaling pathways is implicated in the regulation 
of cell fate specification and proliferative capacity in the   
intestine (Fre et al., 2005; Nateri et al., 2005; van Es et al., 
2005; Sancho et al., 2009). Our work demonstrates an im-
portant role of Fbxw7 in these processes. In addition, Muc2 
expression was also reduced in Fbxw7G intestines. Collec-
tively, our results (Fig. S5, A–F), along with previous work 
(Fre et al., 2005; Nateri et al., 2005; van Es et al., 2005; Sancho 
et al., 2009), suggest that these signals maintain the homeo-
static control of intestinal epithelium.
Recent  studies  have  demonstrated  that  alterations  in 
Notch and c-Jun signals could also be involved in Fbxw7G 
Figure 8.  Accumulation of proliferating 
cells in the crypts of ApcMin/+Fbxw7G 
mice. (A and B) IHC for Ki67 expression (left) 
and quantification of Ki67+ cells (right) from 
intestines of day 3 postpartum mice (A) or 
from crypts of 3-wk-old mice (B; >200 crypts 
in each mouse; n = 3 of each genotype). Error 
bars represent mean ± SEM (***, P < 0.001). 
Bars, 50 µm. (C) Protein extracts from small 
intestine of 3-d-postpartum mice of indicated 
genotypes were analyzed by Western blotting. 
The asterisk indicates a nonspecific band. The 
experiment was repeated twice.308 FBXW7 in intestinal homeostasis and cancer | Babaei-Jadidi et al.
for fighting colon cancer. Moreover, given the reduced life-
span and increased incidence of intestinal tumors and mortality 
in ApcMin/+Fbxw7G mice, these mice could be useful for test-
ing carcinogens and drug screening.
MATERIALS AND METHODS
Mouse lines. Floxed Fbxw7 (Fbxw7fl/fl) mice (Fig. S1) were backcrossed a 
minimum of five times to a C57BL/6 background; Villin-Cre transgenic 
mice (el Marjou et al., 2004) and ApcMin/+ mice (Fodde, 2002) were on a 
C57BL/6  genetic  background  (Nateri  et  al.,  2005).  Villin-Cre+Fbxw7fl/fl 
(Fbxw7G) mice were generated by interbreeding mice carrying Fbxw7fl/fl 
and the Villin-Cre allele. ApcMin/+Fbxw7fl/fl mice were generated by inter-
breeding mice carrying the floxed alleles of Fbxw7 (Fbxw7fl/fl) and ApcMin/+, 
and then ApcMin/+Fbxw7fl/fl were intercrossed with the Villin-Cre+Fbxw7fl/fl 
(Fbxw7G). In all experiments, only littermates were used and compared. 
Mice were maintained in a specific pathogen-free condition. All experi-
ments were performed at the University of Nottingham in accordance with 
institutional biomedical service unit guidelines.
Histology and IHC. Intestines were removed, flushed with cold PBS, and 
processed as “Swiss roll” gut preparations as described previously (Nateri   
et al., 2005). Tissues were fixed overnight in 10% neutral-buffered formalin, 
paraffin embedded, and sectioned at 4-µm thickness for hematoxylin and 
eosin (H&E) staining or IHC with the following primary antibodies: active 
caspase-3,  c-Jun,  and  p–c-Myc  (Cell  Signaling  Technology);  lysozyme, 
Chromogranin  A,  and  CD44s  (Millipore);  anti-Ki67  (Dako);  Notch  1, 
Notch 4, and Muc2 (Santa Cruz Biotechnology, Inc.); -catenin (BD); 
DEK (Abcam); and Fbxw7 (Thermo Fisher Scientific). Where antigen re-
trieval was required, slides were microwaved in Na citrate buffer, pH 6, for 
12 min. All secondary antibodies were biotinylated (Vector Laboratories), 
and after incubation with avidin–biotin complex (VectaStain ABC kit; Vec-
tor Laboratories), sections were developed with diaminobenzidine. Alkaline 
phosphatase, periodic acid Schiff (Sigma-Aldrich), and Alcian blue (BDH) 
were used to identify intestinal cell types according to manufacturers. In 
adult mice, the Ki67-positive cells per crypt were measured and/or the cas-
pase-3 in 200 full crypts or villi was scored from at least three mice of each 
genotype. Data for caspase-3 are represented as percentage over control ± 
SEM. In 3-d-postnatal mice, Ki67+ cells were scored from three mice and 
measured per micrometer, and data are represented in comparison with lit-
termate control ± SEM.
Human CRC specimens from a total of five cases with and six cases 
without  FBXW7  mutations  were  obtained  on  separate  slides/sections. 
FBXW7 mutations without loss of heterozygosity were identified by se-
quencing analysis. Ethical approval and research and development approval 
were obtained from the Local Research Ethics Committee and the Trust 
Research and Development office, respectively, in Oxford. For IHC, sec-
tions were dewaxed with xylene, rehydrated through graded alcohol, and 
then boiled in 0.01 M Na citrate buffer, pH 6, for 10 min for antigen re-
trieval.  Immunostaining  was  performed  as  outlined  above  for  DEK  and 
TPM antibodies. Staining was evaluated semiquantitatively using an ordinal 
score scale of 1 = lowest staining and 4 = extensive intense staining. Staining 
was evaluated independently by four observers. Statistical analysis was per-
formed using SPSS, and FBXW7 statuses were examined for both DEK and 
TPM for each tumor using the mean of scores ± SD, and a p-value <0.05 
was considered statistically significant.
ISH. The mouse Fbxw7 RNA probe was generated from an 800-bp mouse 
Fbxw7 PCR product (confirmed by sequencing) transcribed with T7 RNA 
polymerase using the DIG RNA labeling mix (Roche). In brief, 4% PFA-
fixed intestinal Swiss roll preparations were sectioned (8 µm), dewaxed, re-
hydrated, digested with 10 µg/ml proteinase K (37°C for 18 min), and then 
incubated in 0.2 M HCl and refixed. After prehybridization for 1 h, slides 
were hybridized overnight at 57°C in buffer containing 50% deionized 
formamide, 10% dextran sulfate, 1× Denhardt’s solution, 10 mM Tris-HCl, 
association of epithelial TPM down-regulation in colorectal 
tumors with FBXW7 mutation (Fig. 5, H vs. L) and our data 
showing restored expression of TPM1- in CRC cells (Fig. 5 P) 
support the conclusion that TPM suppression is required in 
the sequence leading from FBXW7 depletion to loss of cell 
growth regulation (Bharadwaj and Prasad, 2002; Varga et al., 
2005; Zhu et al., 2007; Zheng et al., 2008; Mlakar et al., 
2009). Nevertheless, TPMs exhibit substantial diversity in 
terms of their size, binding affinity to actin, subcellular local-
ization, and in interactions with other proteins, suggesting 
that individual TPMs may differ in their biological functions: 
cell migration and invasion (Miyado et al., 1996; Gunning   
et al., 2005; Gupton et al., 2005). In parallel to 3-d-postnatal 
ApcMin/+Fbxw7G mice (Fig. 5, D vs. C), and in line with a 
role for DEK in tumorigenesis (Wise-Draper et al., 2009), we 
also showed that human DEK is highly expressed in human 
CRC  tissues  and  is  correlated  significantly  with  FBXW7 
(Fig. 5, N vs. J; and Table S3) mutation and also mediates cell 
division (Fig. S5). Beyond the current scope of this paper, 
further contribution of DEK and TPM functions could be 
compared with other effects of Fbxw7.
Mechanistically, biochemical analysis showed that DEK 
degradation is mediated by GSK-3–SCFFbxw7 and that the 
knockdown or overexpression of Fbxw7 reversibly affects 
the level of DEK (Figs. 4 and 6). Of note, DEK transcript 
levels were unchanged, suggesting that DEK is not transcrip-
tionally regulated by activated Notch and/or c-Jun signaling 
pathways. In addition, we showed that p-DEK changes the 
alternative RNA splicing of TPM and that the knockdown 
or overexpression of DEK can be inversely correlated with 
the levels of different isoforms of TPM (Fig. 7). These find-
ings therefore suggest that aberrant DEK-TPM signaling after 
loss of the Fbxw7 causes loss of cell growth regulation and 
consequently, after APC loss and -catenin accumulation, 
promote adenoma progression to adenocarcinoma in our 
double mutant ApcMin/+Fbxw7G mice. However, further in 
vivo analysis would be required to validate this concept by 
genetic intercrosses and generation of Tpm- and/or Dek- 
deficient mice. Heterozygous deletion of Fbxw7 in Fbxw7G/fl 
mice with no significant abnormality phenotype may pheno-
copy FBXW7 mutations in human CRC with no loss of a 
second allele and may function as a haploinsufficient tumor 
suppressor (Rajagopalan et al., 2004; Kemp et al., 2005). Fur-
ther analysis, beyond the current scope of this paper, would 
be required to validate this concept in ApcMin/+ mice.
We conclude that Fbxw7 mutation causes failed intestinal 
differentiation and increased proliferation and occurs in the 
absence of cyclin E and c-Myc accumulation. Fbxw7 muta-
tion  results  in  accumulation  of  multiple  substrates  and  in   
impaired degradation of Notch, Jun, and DEK, which coop-
eratively contribute to carcinogenesis (Fig. S8 F). Consistent 
with this model, an intact and functional Fbxw7 is thought to 
restore homeostatic control mechanisms and impair onco-
genic activators. Therefore, strategies based on the partial de-
livery of Fbxw7- to intestinal tumor cells would attenuate 
nuclear DEK and -catenin accumulation and show promise JEM VOL. 208, February 14, 2011 
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plasmid was a gift from B.W. O’Malley (Baylor College of Medicine, Houston, 
TX; Wu et al., 2007), human DEK-GFP construct was a gift from J. Valcarcel 
(Centre de Regulació Genòmica, Barcelona, Spain) and A. Bürkle (Univer-
sity of Konstanz, Konstanz, Germany; Soares et al., 2006), and FLAG–Tpm1- 
was a gift from J. Huot (Le Centre de recherche en cancérologie de 
l’Université Laval, Québec, Québec, Canada; Houle et al., 2007). To mea-
sure proliferation, HCT116 cells were transfected with an enhanced GFP 
expression  vector  (pC2-EGFP;  Takara  Bio  Inc.)  and/or  with  sequence 
scrambled controls and siDEK duplexes (Invitrogen) and peGFP-DEK   
vector. Transfection efficiency judged by enhanced GFP expression was   
50–60%. 36 h after transfection, cells were collected by centrifugation, ethanol 
(70%) fixed, and treated with 50 µg DNase-free RNase/ml for 30 min, and 
DNA was stained with 50 µg propidium iodide/ml and analyzed by FACS. 
All assays were performed at least three times.
Cell migration, wound healing, and colony forming assays. Cell mi-
gration was measured using 24-well plates with polycarbonate membrane 
trans-well inserts with an 8-µm pore size (Corning). 2.5 × 104 cells were 
seeded, and cell migration was assessed after 24 h by fixing the cells attached 
to the lower surface in 10% methanol for 30 min. Cells were then stained 
with methylene blue and manually counted. Cell wound healing assays were 
performed in 6-well dishes. Cells were grown to >90% confluence and then 
starved in low serum media (0.1% serum in RPMI) for 24 h. A sterile 200-µl 
pipette tip was used to scratch three separate wounds. Healing across the 
wound line was assessed at 24 h. Images were analyzed using the ImageJ 
analysis program (National Institutes of Health), and the area of the wound 
was measured. For the wound healing assays, total pixel numbers with an in-
tensity value of 0 were analyzed. All assays were performed at least three 
times in triplicate. Colony forming assay was performed using single cell sus-
pensions, and 50 live cells (stained with Trypan blue) were plated in a 24-
well precoated poly-l-lysine plate. After 2 d of incubation, single GFP+ve 
cells and, after 7 d, colonies were identified for fluorescent microscopy ex-
periments. Colonies were counted after 2 wk, and images were captured. 
Images were analyzed using the ImageJ analysis program, and the area of the 
colony was measured as outlined above. The experiments were repeated in 
triplicate and on two separate occasions.
Western blot analysis. Mice were sacrificed by cervical dislocation, and 
the intestines were removed and flushed extensively with cold PBS. The first 
3 cm of the small intestine and large bowel were taken and homogenized in 
RIPA  lysis  buffer  (Sigma-Aldrich)  supplemented  with  protease  inhibitor 
cocktail (Sigma-Aldrich). Immunoblots were performed as previously de-
scribed (Nateri et al., 2005). Equal amount of total protein was denatured in 
the SDS sample loading buffer, separated on 8–16% SDS–polyacrylamide 
gradient gels, and transferred to polyvinylidene fluoride membranes, which 
were immunoblotted with various antibodies as indicated. Antibodies   
to polyclonal anti-Fbxw7 (Thermo Fisher Scientific and Invitrogen); cyclin 
E, c-Jun, p–c-JunS63, and p–c-MycT58/S62 (Cell Signaling Technology); 
DEK and -actin (Abcam); and Notch 1 and Notch 4 (Santa Cruz Biotech-
nology, Inc.) were used. Antibodies to monoclonal GFP were obtained from 
Invitrogen, and antibodies to FLAG and hemagglutinin (HA) were obtained 
from Sigma-Aldrich. Western blot analysis for HCT116 and HEK293T   
cells was performed as previously described (Nateri et al., 2004). Cells 
were treated with LiCl (Sigma-Aldrich) and MG132 proteasome inhibitor 
(EMD) when required. The experiments were repeated on at least three 
separate occasions.
Co-IP and HA ubiquitination assay. Here we used 100 µl of anti-FLAG–
conjugated agarose beads (Sigma-Aldrich) to immunoprecipitate Fbxw7 from 
whole cell extracts of the HEK293T cells using RIPA buffer (150 mM NaCl) 
with protease inhibitors. After IP, the beads were washed thoroughly with 
RIPA buffer adjusted to 500 mM. Immunoprecipitated proteins were eluted 
using 2× SDS loading buffer and then boiled at 95°C for 4 min. Denatured 
proteins were subsequently separated on 10% SDS PAGE and immunoblotted 
against anti-GFP and anti-HA antibodies as required after transferring to 
pH 7.6, 600 mM NaCl, 0.25% Na dodecyl sulfate, 1 mM EDTA, 2 mg/ml 
transfer RNA, and 2 µg/ml denatured digoxigenin–labeled cRNA probe. 
The slides were rinsed in 5× SSC at 57°C for 10 min, washed once in 50% 
formamide in 2× SSC at 57°C for 30 min, and then once in 2× SSC at 57°C 
for 30 min and twice in 0.2× SSC for 30 min each at 57°C. After blocking 
with 1% blocking reagent (Roche), slides were incubated with sheep anti-
digoxigenin fab antibody (1:1,000; Roche) for 2 h at 37°C. Substrate was   
developed using NBT/BCIP.
qRT-PCR analysis. For qRT-PCR analysis, total RNA was isolated from 
freshly  dissected  intestines  using  TRIZOL  reagent  (Sigma-Aldrich)  and   
purified using the RNeasy mini kit including DNase (QIAGEN) according   
to the manufacturer’s instructions. cDNA synthesis was performed using   
Superscript reagents (Invitrogen) according to the manufacturer’s instructions. 
Quantitative real-time PCR was accomplished with SYBR green incorpo-
ration (Platinum Quantitative PCR SuperMix-UDG w/ROX; Invitrogen) 
using an ABI7900HT (Applied Biosystems), and the data were analyzed using 
SDS 2.3 software (Applied Biosystems). Results were normalized to those 
obtained with -actin, and data are presented as fold induction/repression 
over control mice. Details of primers used are shown in Table S1. All assays 
were performed in triplicate at least three times.
Proteomic assays. Intestinal samples from young (≤5 wk) mutant Fbxw7G 
and control Fbxw7fl/fl mice were initially homogenized with ice-cold PBS, 
and protein extracts were derived following fractionation cytosolic and nu-
clear extracts according to the manufacturer’s instructions (BioVision), resus-
pended  in  two-dimensional  lysis  buffer  (Kim  et  al.,  2007),  and  loaded 
separately onto Immobiline DryStrip gels containing a preformed pH gradient 
(pH 3–10), and proteins were run on the Protean IEF Cell (Bio-Rad Labo-
ratories) according to the manufacturer’s instructions, separated on a 12% 
polyacrylamide gel, and then stained with Coomassie blue. Gels were 
scanned on a calibrated imaging densitometer (GS-800; Bio-Rad Laborato-
ries), and images were analyzed using PDQuest (Bio-Rad Laboratories). All 
assays were performed at least three times. For an accurate determination of 
the weight of the novel protein or proteins, MALDI-MS provided by the 
protein chemistry facility with a Mass-Prep robotic liquid handling system 
and MALDI TOF mass spectrometer (Waters Corporation) in the School of 
Biomedical Sciences, University of Nottingham was used. Peak lists were 
entered  into  MASCOT  PMF  (http://www.matrixscience.com/search_
form_select.html)  and  ExPASy  (http://www.expasy.org/tools/aldente/) 
database search engines.
Crypt/villus  isolation.  Intestinal  epithelia  were  released  from  murine 
small intestine by incubation for 30 min at 4°C in PBS containing 2 mM 
EDTA as previously described (Sato et al., 2009), and immunoblots were 
performed as previously described (Nateri et al., 2005).
Survival curve. Kaplan–Meier survival analysis was used for Fbxw7GApcMin/+ 
mice and their transgenic littermate (Fbxw7fl/flApcMin/+, Fbxw7G) mice over 
a period of 62 wk (435 d; n = 14). The survival curve shows the percentage 
of mice remaining alive at 1-wk intervals. The x axis indicates times (in 
weeks) until mice were euthanized because of severe weight loss and anemia. 
14 mice for each genotype group were used, and the survival curves were 
significantly different from each other (P < 0.001).
Cell culture, transfection, and cell cycle assays. Human CRC HCT116 
and HEK293T cells were maintained in RPMI supplemented with 10% 
FBS. HCT116 cell lines harboring deletion of FBXW7 were a gift from   
A. Balmain (University of California, San Francisco, San Francisco, CA) and 
B. Vogelstein (Ludwig Center, Johns Hopkins University, Baltimore, MD; 
Mao et al., 2004a, 2008). Transfection of plasmids encoding FBXW7-, -, 
and -, DEK, GSK-3, Tpm1- (available from GenBank/EMBL/DDBJ 
under accession no. NM_000366), Luc, -gal, GFP (control), or siRNA 
duplexes along with others was performed using Lipofectamine 2000 reagent 
(Invitrogen) according to the manufacturer’s instruction. FLAG–GSK-3 310 FBXW7 in intestinal homeostasis and cancer | Babaei-Jadidi et al.
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polyvinylidene fluoride membranes as previously described (Wu et al., 2007). 
The experiments were repeated on at least two separate occasions.
Pulse-chase.  HEK293T  cells  were  transfected  with  DEK  wild-type   
(DEKwt) and/or DEK phosphorylation mutant (DEKT15,67A or DEK2A) with 
Fbxw7-expressing plasmids. 30 h after transfection, cells were radioactively 
labeled for 3 h with 0.2 mCi [35S]methionine and [35S]cysteine/ml in a labeling 
medium lacking methionine and cysteine (ICN), followed by chase in com-
plete medium with 1% FCS serum. Cell extracts and IP were performed with 
rabbit polyclonal antibody to GFP agarose-conjugated beads (Abcam) as pre-
viously described (Nateri et al., 2004).
Splicing efficiency assays. Activity of Luc and -Gal proteins was mea-
sured using a Dual-Light reporter system (Applied Biosystems) according to 
the manufacturer’s instruction. The reporter assays were performed in tripli-
cates using a multifunction microplate reader (FLUOstar OPTIMA; BMG 
Labtech) after transient transfection of the bicistronic reporter along with 
plasmids  encoding  DEK,  FBXW7-,  GSK-3,  and  GFP  (control)  into 
HCT116 cells. For statistical analysis, the ratio of Luc activity to -Gal was 
obtained from three independent experiments. Mean ± SD (n = 3; P < 0.001) 
values are shown. RT-PCR analysis of total RNA isolated from transfected 
cells represents an independent experiment but parallel to the reporter assay. 
DNA bands were derived from spliced and unspliced RNA.
Statistics. The significance of differences between mean and median was 
determined using the Student’s t test and the Mann-Whitney U test, as appro-
priate. Significance testing was performed using SPSS version 15. Mean ± SD 
(n = 3; *, P < 0.05; **, P < 0.01; ***, P < 0.001) values are shown.
Online supplemental material. Fig. S1 shows the generation and charac-
terization of intestinal (gut)-specific Fbxw7 knockout (Fbxw7G) mice. Fig. S2 
shows that intestinal targeted inactivation of Fbxw7 leads to colonic and intes-
tinal polyposis. Fig. S3 shows polyps and adenomas in ApcMin/+Fbxw7G mice 
at an early age (3 wk old). Fig. S4 shows that a very small number and size   
of intestinal polyps/adenomas appeared from 3-wk-old ApcMin/+ mice with   
-cateninHigh staining. Fig. S5 shows Fbxw7G lineage potential and elevation 
of Fbxw7 substrate expression upon depletion of Fbxw7 in mouse intes-
tine. Fig. S6 shows IHC for c-Jun and FBXW7-, -, and - protein iso-
forms. Fig. S7 shows Western blot analysis of TPM protein expression upon 
overexpression of FBXW7s and phosphorylation of human DEK protein by 
GSK-3. Fig. S8 shows cell growth regulation by human DEK and TPM1-   
proteins. Table S1 lists primers used for genotyping and qRT-PCR. Table S2 
lists TPM and DEK expression scores in sections from human colorectal tu-
mor tissues with and without FBXW7 mutations. Table S3 shows the score 
quantification of TPM and DEK IHC performed in FBXW7wt and FBX-
W7mut human colorectal tumors. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20100830/DC1.
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